Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | TSHR | P16473 | 3/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.58 |
| ▸ | HPGD | P15428 | 7/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 9/20 | 0.55 |
| ▸ | TP53 | P04637 | 7/20 | 0.55 |
| ▸ | MAPT | P10636 | 6/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4943540 | 0.89 | KDM4E (0.72) | HSD17B10KDM4ESMN1; SMN2TSHRGAA | |
| SCHEMBL4935332 | 0.88 | HSD17B10 (0.82) | HSD17B10KDM4ESMN1; SMN2TSHRGAA | |
| SCHEMBL4778302 | 0.85 | HSD17B10 (0.73) | HSD17B10KDM4ESMN1; SMN2TSHRGAA | |
| SCHEMBL4776468 | 0.84 | HSD17B10 (0.69) | HSD17B10KDM4ESMN1; SMN2TSHRGAA | |
| SCHEMBL4781087 | 0.84 | TP53 (0.62) | HSD17B10KDM4ESMN1; SMN2TSHRALDH1A1 | |
| SCHEMBL4941774 | 0.84 | HSD17B10 (0.83) | HSD17B10KDM4ESMN1; SMN2TSHRGAA | |
| SCHEMBL4781552 | 0.82 | LMNA (0.61) | HSD17B10KDM4ESMN1; SMN2TSHRALDH1A1 | |
| SCHEMBL4933302 | 0.81 | HSD17B10 (0.68) | HSD17B10KDM4ESMN1; SMN2TSHRGAA | |
| SCHEMBL4779630 | 0.81 | KDM4E (0.63) | HSD17B10KDM4ESMN1; SMN2TSHRGAA | |
| SCHEMBL4782331 | 0.81 | HSD17B10 (0.74) | HSD17B10KDM4ESMN1; SMN2TSHRGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080221129-A1 | New compounds | BIOVITRUM AB (PUBL) (SE) | 2008-09-11 | — | — | US | disclosed |
| WO-2008003753-A1 | PYRAZOLO [1,5-A] PYRIMIDINE ANALOGS FOR USE AS INHIBITORS OF STEAROYL-COA DESATURASE (SCD) ACTIVITY | BIOVITRUM AB (PUBL) (SE) | 2008-01-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080221129-A1 | New compounds | SCD, SCD5, FASN | HSD17B10 47/4885KDM4E 3813/4885SMN1; SMN2 2914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.